These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 33242422)

  • 1. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A; Ibáñez K; Shankaracharya FNU; Keagle P; Rossi G; Caroppo P; Tagliavini F; Waldo ML; Johansson PM; Nilsson CF; ; ; ; ; ; ; ; ; Rowe JB; Benussi L; Binetti G; Ghidoni R; Jabbari E; Viollet C; Glass JD; Singleton AB; Silani V; Ross OA; Ryten M; Torkamani A; Tanaka T; Ferrucci L; Resnick SM; Pickering-Brown S; Brady CB; Kowal N; Hardy JA; Van Deerlin V; Vonsattel JP; Harms MB; Morris HR; Ferrari R; Landers JE; Chiò A; Gibbs JR; Dalgard CL; Scholz SW; Traynor BJ
    Neuron; 2021 Feb; 109(3):448-460.e4. PubMed ID: 33242422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
    Niblock M; Smith BN; Lee YB; Sardone V; Topp S; Troakes C; Al-Sarraj S; Leblond CS; Dion PA; Rouleau GA; Shaw CE; Gallo JM
    Acta Neuropathol Commun; 2016 Feb; 4():18. PubMed ID: 26916632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD.
    Sultana J; Ragagnin AMG; Parakh S; Saravanabavan S; Soo KY; Vidal M; Jagaraj CJ; Ding K; Wu S; Shadfar S; Don EK; Deva A; Nicholson G; Rowe DB; Blair I; Yang S; Atkin JD
    Mol Neurobiol; 2024 Dec; 61(12):10318-10338. PubMed ID: 38722513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early disruption of the CREB pathway drives dendritic morphological alterations in FTD/ALS cortical neurons.
    Jean Gregoire M; Sirtori R; Donatelli L; Morgan Potts E; Collins A; Zamor D; Katenka N; Fallini C
    Proc Natl Acad Sci U S A; 2024 Dec; 121(49):e2406998121. PubMed ID: 39589881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
    Stepto A; Gallo JM; Shaw CE; Hirth F
    Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare variants in MYH15 modify amyotrophic lateral sclerosis risk.
    Kim H; Lim J; Bao H; Jiao B; Canon SM; Epstein MP; Xu K; Jiang J; Parameswaran J; Li Y; Moberg KH; Landers JE; Fournier C; Allen EG; Glass JD; Wingo TS; Jin P
    Hum Mol Genet; 2019 Jul; 28(14):2309-2318. PubMed ID: 30985904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in mitigating TDP-43-related neuropathy in the mouse model of ALS disease.
    Majumder P; Hsu TI; Hu CJ; Huang JK; Lee YC; Hsieh YC; Ahsan A; Huang CC
    Exp Neurol; 2025 Jan; 383():114999. PubMed ID: 39419433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
    Seddighi S; Qi YA; Brown AL; Wilkins OG; Bereda C; Belair C; Zhang YJ; Prudencio M; Keuss MJ; Khandeshi A; Pickles S; Kargbo-Hill SE; Hawrot J; Ramos DM; Yuan H; Roberts J; Sacramento EK; Shah SI; Nalls MA; Colón-Mercado JM; Reyes JF; Ryan VH; Nelson MP; Cook CN; Li Z; Screven L; Kwan JY; Mehta PR; Zanovello M; Hallegger M; Shantaraman A; Ping L; Koike Y; Oskarsson B; Staff NP; Duong DM; Ahmed A; Secrier M; Ule J; Jacobson S; Reich DS; Rohrer JD; Malaspina A; Dickson DW; Glass JD; Ori A; Seyfried NT; Maragkakis M; Petrucelli L; Fratta P; Ward ME
    Sci Transl Med; 2024 Feb; 16(734):eadg7162. PubMed ID: 38277467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.
    Clarke BE; Ziff OJ; Tyzack G; Howe MP; Wang Y; Klein P; Smith CA; Hall CA; Helmy A; Howell M; Kelly G; Patani R
    Mol Neurodegener; 2024 Nov; 19(1):90. PubMed ID: 39593143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural interventions to treat anxiety in adults with autism and moderate to severe intellectual disabilities: the BEAMS-ID feasibility study.
    Langdon PE; Apanasionok MM; Scripps E; Bunning K; Filipczuk M; Gillespie D; Hastings RP; Jahoda A; McNamara R; Rai D; Gray KM
    Health Technol Assess; 2024 Oct; 28(72):1-147. PubMed ID: 39487624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Contributions to Alzheimer's Disease and Frontotemporal Dementia in Admixed Latin American Populations.
    Acosta-Uribe J; Piña Escudero SD; Cochran JN; Taylor JW; Castruita PA; Jonson C; Barinaga EA; Roberts K; Levine AR; George DS; ÁvilaFunes JA; Behrens MI; Bruno MA; Brusco LI; Custodio N; Duran-Aniotz C; Lopera F; Matallana DL; Slachevsky A; Takada LT; Zapata-Restrepo LM; Durón-Reyes DE; de Paula França Resende E; Gelvez N; Godoy ME; Maito MA; Javandel S; Miller BL; Nalls MA; Leonard H; Vitale D; Bandres-Ciga S; Koretsky MJ; Singleton AB; Pantazis CB; Valcour V; Ibañez A; Kosik KS; Yokoyama JS;
    medRxiv; 2024 Nov; ():. PubMed ID: 39574875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.
    King A; Al-Sarraj S; Troakes C; Smith BN; Maekawa S; Iovino M; Spillantini MG; Shaw CE
    Acta Neuropathol; 2013 Feb; 125(2):303-10. PubMed ID: 23053136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis.
    Dratch L; Owczarzak J; Mu W; Cousins KAQ; Massimo L; Grossman M; Erby L
    J Genet Couns; 2024 Jun; 33(3):515-527. PubMed ID: 37424394
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.